1. Home
  2. SNN vs BIO Comparison

SNN vs BIO Comparison

Compare SNN & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNN
  • BIO
  • Stock Information
  • Founded
  • SNN 1856
  • BIO 1952
  • Country
  • SNN United Kingdom
  • BIO United States
  • Employees
  • SNN N/A
  • BIO N/A
  • Industry
  • SNN Industrial Specialties
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • SNN Health Care
  • BIO Industrials
  • Exchange
  • SNN Nasdaq
  • BIO Nasdaq
  • Market Cap
  • SNN 11.0B
  • BIO 9.6B
  • IPO Year
  • SNN 1999
  • BIO N/A
  • Fundamental
  • Price
  • SNN $25.72
  • BIO $353.91
  • Analyst Decision
  • SNN Strong Buy
  • BIO Strong Buy
  • Analyst Count
  • SNN 1
  • BIO 4
  • Target Price
  • SNN N/A
  • BIO $414.00
  • AVG Volume (30 Days)
  • SNN 1.1M
  • BIO 154.6K
  • Earning Date
  • SNN 02-25-2025
  • BIO 02-13-2025
  • Dividend Yield
  • SNN 2.92%
  • BIO N/A
  • EPS Growth
  • SNN 39.77
  • BIO N/A
  • EPS
  • SNN 0.35
  • BIO N/A
  • Revenue
  • SNN $5,642,000,000.00
  • BIO $2,580,209,000.00
  • Revenue This Year
  • SNN $6.24
  • BIO N/A
  • Revenue Next Year
  • SNN $4.92
  • BIO $2.92
  • P/E Ratio
  • SNN $36.51
  • BIO N/A
  • Revenue Growth
  • SNN 5.48
  • BIO N/A
  • 52 Week Low
  • SNN $23.65
  • BIO $262.12
  • 52 Week High
  • SNN $31.72
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • SNN 62.77
  • BIO 61.58
  • Support Level
  • SNN $23.69
  • BIO $334.57
  • Resistance Level
  • SNN $27.10
  • BIO $355.05
  • Average True Range (ATR)
  • SNN 0.46
  • BIO 10.56
  • MACD
  • SNN 0.18
  • BIO 1.65
  • Stochastic Oscillator
  • SNN 59.38
  • BIO 96.44

About SNN Smith & Nephew SNATS Inc.

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: